D-Wave Quantum Inc. has partnered with Japan Tobacco's pharmaceutical division to develop a proof-of-concept AI model utilizing quantum technology for drug discovery. The project aims to enhance the training accuracy of AI models used to generate drug molecules, outperforming traditional methods. By leveraging quantum processing units, the initiative seeks to expedite the identification of effective small-molecule drugs for various diseases, potentially reducing costs and time in the drug development process.
